RxDoctor Payments Data

Brian Holly, MD

Vascular & Interventional Radiology · Baltimore, MDNPI 1386846277

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,657 of the $5,941 with a category attached, or 78.4%. Penumbra, Inc. accounts for 65.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $2,664 and has fallen 65.6% since, to $917 in 2025.

$5,941in general payments, 2019–2025

Across 53 payments — averaging $112.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$4K
  • Boston Scientific$959
  • Terumo Medical Corporation$247
  • Johnson & Johnson$197
  • Inari Medical, Inc.$146
  • Medtronic$124
  • plus $382 from 5 others

What the payments were for

  • Travel & lodging$1,28322%
  • Food & beverage$4,65778%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,941 in reported general payments places this provider in the 70th percentile of 75 vascular & interventional radiology providers in Maryland.

See all vascular & interventional radiology providers in Maryland

Medicare billing

Part B allowed, 2024
$137,076
Medicare patients
284
Services billed
1,315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →